Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)

Personal Subscription
Become EABM
Become Reviewer

Articles Ahead of Print

Covid-19 in Man: A Very Dangerous Affair

Volume:21
Giuseppe Lisco, Vito A. Giagulli, Giovanni De Pergola, Anna De Tullio, Edoardo Guastamacchia and Vincenzo Triggiani*

Investigation of ACE rs4646994, MTHFR rs1801133 and VDR rs2228570 Genotypes in Jordanian Patients with Fibromyalgia Syndrome

Volume:21
Raida Khalil, Wajdy J. Al-Awaida, Hamzeh J. Al-Ameer*, Yazun Jarrar, Amer Imraish, Omar Al bawareed, Rand Qawadri, Farah Al Madhoon and Loiy Obeidat

The Skeletal Effects of Gonadotropin-Releasing Hormone Antagonists: A Concise Review

Volume:21
Nur-Vaizura Mohamad, Ima-Nirwana Soelaiman and Kok-Yong Chin*

The Assessment of Some Metabolic Markers by Combination of Ursolic Acid Supplementation and Resistance Training in Young Older Obese Women

Volume:21
Ehsan Asghari, Seyyed Reza Attarzadeh Hosseini, Mina Kiania, Tahereh Farkhondeh, Hamid Arazi and Saeed Samarghandian*

Negative Correlation between Neuregulin-4 and IL-9 Serum Levels in Patients with Coronary Artery Disease

Volume:21
Hossein Farshidi, Nadereh Naderi, Hossein Montazerghaem, Narges Farshidi and Mahsa Rahimzadeh*

Study of Cord Blood Levels of Erythropoietin, Bilirubin and Reticulocyte Count as Early Predictors of Neonatal Hyperbilirubinemia

Volume:21
Mohamed Shawky Elfarargy*, Ghada M Al-Ashmawy, Sally Abu-Risha and Haidy Khattab